Stay updated on Nivolumab in Resectable NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.

Latest updates to the Nivolumab in Resectable NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded a government-status notice and a v3.2.0 revision; removed the v3.1.0 revision. The page now informs users about potential delays and where to check current operating status, and indicates the new version.SummaryDifference1%
- Check25 days agoChange DetectedUpdated software revision from v3.0.2 to v3.1.0, indicating a new version release.SummaryDifference0.0%
- Check39 days agoChange DetectedVersion upgraded to v3.0.2; the Back to Top element was removed.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%
- Check54 days agoChange DetectedThe web page has undergone significant updates, including the addition of a new facility name and location in Montreal, Quebec, Canada, along with expanded drug information for several agents. Notably, previous drug information has been removed, indicating a shift in focus or available treatments.SummaryDifference2%
- Check61 days agoChange DetectedThe page has removed the phrase 'Last Update Posted (Estimated)' and replaced it with 'Last Update Posted'.SummaryDifference0.0%
Stay in the know with updates to Nivolumab in Resectable NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.